DEA Promises Progress on Federal Cultivation Applications, But Provides No Timetable for Action
NORML
AUGUST 26, 2019
The US Drug Enforcement Administration (DEA) has once again pledged to take action to better facilitate clinical cannabis research. In 2016, the DEA similarly announced the adoption of new rules to expand to supply of research-grade cannabis, but failed to take any further action.
Let's personalize your content